A Structural Model of the Staphylococcus aureus ClfA–Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics
2008

Understanding the Interaction Between Staphylococcus aureus ClfA and Fibrinogen

publication 10 minutes Evidence: high

Author Information

Author(s): Ganesh Vannakambadi K., Rivera Jose J., Smeds Emanuel, Ko Ya-Ping, Bowden M. Gabriela, Wann Elisabeth R., Gurusiddappa Shivasankarappa, Fitzgerald J. Ross, Höök Magnus

Primary Institution: Center for Extracellular Matrix Biology, Institute of Biosciences and Technology, Texas A & M University Health Science Center

Hypothesis

The study aims to characterize the binding mechanism of ClfA from Staphylococcus aureus to fibrinogen.

Conclusion

The findings suggest that ClfA can bind to fibrinogen in a way that may allow for the design of new anti-staphylococcal therapeutics.

Supporting Evidence

  • ClfA is a major virulence factor in Staphylococcus aureus infections.
  • The study identified specific residues in fibrinogen that interact with ClfA.
  • Peptides that selectively antagonize the ClfA-fibrinogen interaction were identified.
  • The binding mechanism of ClfA to fibrinogen differs from that of other similar proteins.

Takeaway

This study looks at how a protein from a germ called Staphylococcus aureus sticks to a blood protein called fibrinogen, which could help create new medicines to fight infections.

Methodology

The study used biochemical and structural analyses, including crystallography and binding assays, to investigate the ClfA-fibrinogen interaction.

Digital Object Identifier (DOI)

10.1371/journal.ppat.1000226

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication